BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29268797)

  • 1. The unresolved problem of beta-2 microglobulin amyloid deposits in the intervertebral discs of long-term dialysis patients.
    Tsai TT; Kaliya-Perumal AK; Jenq CC; Niu CC; Ho NY; Lee TY; Lai PL
    J Orthop Surg Res; 2017 Dec; 12(1):194. PubMed ID: 29268797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of gastrointestinal beta2-microglobulin amyloidosis correlates with time on dialysis.
    Jimenez RE; Price DA; Pinkus GS; Owen WF; Lazarus JM; Kay J; Turner JR
    Am J Surg Pathol; 1998 Jun; 22(6):729-35. PubMed ID: 9630180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological analysis of the ligamentum flavum of patients with dialysis-related spondyloarthropathy.
    Inatomi K; Matsumoto T; Tomonaga T; Eto M; Shindo H; Hayashi T; Konishi H
    J Orthop Sci; 2004; 9(3):285-90. PubMed ID: 15168185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical discs are most susceptible to beta 2-microglobulin amyloid deposition in the vertebral column.
    Ohashi K; Hara M; Kawai R; Ogura Y; Honda K; Nihei H; Mimura N
    Kidney Int; 1992 Jun; 41(6):1646-52. PubMed ID: 1501421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Destructive spondylodiskopathy in beta 2 microglobulin-induced amyloidosis].
    Schober R; Passlick J; Kiwit JC; Frenzel H; Linke RP
    Pathologe; 1990 May; 11(3):154-7. PubMed ID: 2197617
    [No Abstract]   [Full Text] [Related]  

  • 6. [Serum level and organ deposits of beta 2-microglobulin in dialysis patients].
    Stein G; Schneider A; Toss H; Linke R; Schaefer K; Ritz E
    Klin Wochenschr; 1990 Nov; 68(22):1150-5. PubMed ID: 2280578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histological characteristics of sternoclavicular beta 2-microglobulin amyloidosis and clues for its histogenesis.
    Garbar C; Jadoul M; Noël H; van Ypersele de Strihou C
    Kidney Int; 1999 May; 55(5):1983-90. PubMed ID: 10231463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. beta 2 M-amyloidosis and gastrointestinal bleeding after renal transplantation.
    Van Audenhove A; Vandermarliere A; Lerut E; Lodewyckx T; Vanrenterghem Y; Maes B
    Acta Clin Belg; 2003; 58(4):248-50. PubMed ID: 14635534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dialysis-related amyloidosis: late finding or hidden epidemic?
    Dember LM; Jaber BL
    Semin Dial; 2006; 19(2):105-9. PubMed ID: 16551286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrastructural localization of advanced glycation end products and beta2-microglobulin in dialysis amyloidosis.
    Brancaccio D; Gallieni M; Niwa T; Braidotti P; Coggi G
    J Nephrol; 2000; 13(2):129-36. PubMed ID: 10858976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dialysis-related spinal canal stenosis: a clinicopathological study on amyloid deposition and its AGE modification.
    Nokura K; Koga H; Yamamoto H; Kimura A; Tamai H; Yazaki S; Suzuki N; Miyazaki S; Niwa T
    J Neurol Sci; 2000 Sep; 178(2):114-23. PubMed ID: 11018703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic amyloidosis of beta 2 microglobulin type.
    Mazanec K; McClure J; Bartley CJ; Newbould MJ; Ackrill P
    J Clin Pathol; 1992 Sep; 45(9):832-3. PubMed ID: 1401222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Membrane Permeability on Cardiovascular Risk Factors and β2m Plasma Levels in Patients on Long-Term Haemodialysis: A Randomised Crossover Trial.
    Chazot C; Kirchgessner J; Pham J; Vo-Van C; Lorriaux C; Hurot JM; Zaoui E; Grassmann A; Jean G; Marcelli D
    Nephron; 2015; 129(4):269-75. PubMed ID: 25825336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid destructive spondyloarthropathy causing cord compression: related to chronic renal failure and dialysis.
    Davidson GS; Montanera WJ; Fleming JF; Gentili F
    Neurosurgery; 1993 Sep; 33(3):519-22. PubMed ID: 8413887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycosaminoglycans in intervertebral disc amyloid deposits.
    Athanasou NA; Kokubun S; West L; Sallie B; Puddle B
    Eur Spine J; 1995; 4(5):308-12. PubMed ID: 8581533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Destructive spondyloarthropathy with beta 2-microglobulin amyloid deposits in a uremic patient before chronic hemodialysis.
    Morinière P; Marie A; el Esper N; Fardellone P; Deramond H; Remond A; Sebert JL; Fournier A
    Nephron; 1991; 59(4):654-7. PubMed ID: 1766508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum beta2-microglobulin and immunoglobulin levels in young hemodialysis patients.
    Dixit MP; Cabansag MR; Piscitelli J; Greifer I; Silverstein DM
    Pediatr Nephrol; 1999 Feb; 13(2):139-42. PubMed ID: 10229003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary beta2-microglobulin analysis in chronic kidney disease and hemodialyzed patients.
    Michelis R; Sela S; Ben-Zvi I; Nagler RM
    Blood Purif; 2007; 25(5-6):505-9. PubMed ID: 18187941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal involvement of dialysis-related amyloidosis.
    Takahashi S; Morita T; Koda Y; Murayama H; Hirasawa Y
    Clin Nephrol; 1988 Sep; 30(3):168-71. PubMed ID: 3052956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scintigraphic methods to detect beta2-microglobulin associated amyloidosis (Abeta2-microglobulin amyloidosis).
    Floege J; Schäffer J; Koch KM
    Nephrol Dial Transplant; 2001; 16 Suppl 4():12-6. PubMed ID: 11402091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.